Cost-effectiveness of irinotecan in advanced colorectal cancer
- 1 July 2000
- journal article
- Published by Elsevier
- Vol. 11 (7) , 899-900
- https://doi.org/10.1023/a:1008387526321
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialPublished by Elsevier ,2000
- Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancerAnnals of Oncology, 2000
- A retrospective cost-effectiveness analysis of interferon as adjuvant therapy in high-risk resected cutaneous melanomaEuropean Journal Of Cancer, 1997